Skip to main
DLB

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Dolby Laboratories Inc. has reported a 1.6% year-over-year increase in its product and services segment, with growth surpassing the company's initial forecasts due to favorable deal timing. The company's licensing revenue, which constitutes nearly half of its total earnings, is poised for further growth through the adoption of its technologies, driven by strong demand for platforms like Atmos, Vision, and the Imaging Patents. Additionally, Dolby is strategically expanding its revenue model to include SaaS-like solutions linked to patent licensing, providing further potential for robust revenue growth moving forward.

Bears say

Dolby Laboratories is projecting a significant decline in revenue, with a model indicating a 7.5% year-over-year decrease in licensing revenue and a 5.7% drop in products and services for the December quarter. The company is also facing increased operating expenses, contributing to an overall anticipated high-single-digit revenue decline for fiscal 2026, mirroring the declining trends observed in fiscal 2025. Additionally, the gross margins have decreased from 90.8% to 89.8%, reflecting pressures in product and service margins, which further exacerbates the negative financial outlook for Dolby Laboratories.

Dolby Laboratories (DLB) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 4 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $90.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $90.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.